Novo Nordisk remains a Buy, underpinned by strong long-term fundamentals and a promising lead in obesity care with the Wegovy pill. Read more on NVO stock here.
Diamondback Energy (FANG) is rated Strong Buy, with a DCF-based target price of $290 per share, implying ~45% upside. FANG's low production costs ($25.09/BOE) and efficient capital allocation underpin ...
As conflict in the Middle East continues to simmer, Oman is facing a new threat related to oil: Oman’s Environment Authority is warning that an oil spill from a sanctioned tanker carrying Russian ...
Feel free to connect with him or check out his work. He's everywhere — Upwork, YouTube, Spotify, SoundCloud, Collider, LinkedIn, Instagram. Generate a summary of this story Hard sci-fi has a ...